- Published on
Ophthalmology – Cavernous Hemangioma of the Orbit
Cavernous hemangioma of the orbit, also known as a cavernoma, is a benign vascular tumor characterized by a proliferation of dilated vascular channels. It is the most common orbital tumor in adults, accounting for approximately 4–12% of all orbital tumors. The condition is more frequently seen in women and is rare in children. Although histologically benign, it can cause significant clinical problems due to its mass effect within the confined orbital space.
The pathophysiology involves a slow-growing, well-encapsulated vascular lesion that expands over time, leading to progressive compression of surrounding orbital structures. This includes the optic nerve, extraocular muscles, and the globe. The tumor is considered a hamartomatous vascular growth rather than a true neoplasm, and its effects are primarily due to pressure rather than invasion.
Patients typically present with painless, progressive proptosis (forward displacement of the eye), which is the hallmark feature. Other symptoms may include a sensation of pressure, diplopia due to extraocular muscle involvement, and a hyperopic shift in vision caused by posterior displacement of the globe. In advanced cases, compression of the optic nerve can result in vision loss. Many cases are incidentally discovered during imaging performed for unrelated reasons, such as headaches.
On physical examination, there may be measurable proptosis using Hertel exophthalmometry, resistance to retropulsion of the globe, and occasionally dilated episcleral vessels. Funduscopic examination may reveal choroidal folds caused by external compression of the globe. Evaluation for optic nerve involvement is critical and includes assessment of visual acuity, color vision, visual fields, and checking for a relative afferent pupillary defect. Signs such as optic disc edema or atrophy may indicate advanced compression.
Diagnosis is primarily made through imaging. CT and MRI scans of the orbit typically show a well-circumscribed, intraconal mass, often located lateral to the optic nerve. These imaging modalities help confirm the diagnosis and assess the size, location, and effect on surrounding structures.
The differential diagnosis includes other causes of proptosis such as thyroid eye disease, other orbital tumors (e.g., schwannoma, hemangiopericytoma, solitary fibrous tumor), carotid-cavernous fistula, and optic nerve tumors like meningioma or glioma.
Management depends on symptoms and the extent of compression. Many lesions are slow-growing and asymptomatic, and these can be safely observed with regular follow-up. However, surgical removal via orbitotomy is indicated when there is evidence of optic nerve compression, progressive vision loss, significant proptosis, or diagnostic uncertainty. Surgical outcomes are generally excellent, especially when the lesion is not located at the orbital apex, where access is more challenging.
Supportive care may be required if complications such as exposure keratopathy occur due to incomplete eyelid closure; this is typically managed with lubrication and close monitoring. Patients under observation should be educated to seek prompt evaluation if they notice any change in vision or symptoms.
The prognosis is very good. Most patients who are observed remain stable, and those who undergo surgery typically have excellent outcomes with minimal risk of recurrence. The primary complication, if untreated, is visual loss due to optic nerve compression, making timely recognition and appropriate management essential.
Cavernous hemangioma of the orbit, also known as a cavernoma, is a benign vascular tumor characterized by a proliferation of dilated vascular channels. It is the most common orbital tumor in adults, accounting for approximately 4–12% of all orbital tumors. The condition is more frequently seen in women and is rare in children. Although histologically benign, it can cause significant clinical problems due to its mass effect within the confined orbital space.
The pathophysiology involves a slow-growing, well-encapsulated vascular lesion that expands over time, leading to progressive compression of surrounding orbital structures. This includes the optic nerve, extraocular muscles, and the globe. The tumor is considered a hamartomatous vascular growth rather than a true neoplasm, and its effects are primarily due to pressure rather than invasion.
Patients typically present with painless, progressive proptosis (forward displacement of the eye), which is the hallmark feature. Other symptoms may include a sensation of pressure, diplopia due to extraocular muscle involvement, and a hyperopic shift in vision caused by posterior displacement of the globe. In advanced cases, compression of the optic nerve can result in vision loss. Many cases are incidentally discovered during imaging performed for unrelated reasons, such as headaches.
On physical examination, there may be measurable proptosis using Hertel exophthalmometry, resistance to retropulsion of the globe, and occasionally dilated episcleral vessels. Funduscopic examination may reveal choroidal folds caused by external compression of the globe. Evaluation for optic nerve involvement is critical and includes assessment of visual acuity, color vision, visual fields, and checking for a relative afferent pupillary defect. Signs such as optic disc edema or atrophy may indicate advanced compression.
Diagnosis is primarily made through imaging. CT and MRI scans of the orbit typically show a well-circumscribed, intraconal mass, often located lateral to the optic nerve. These imaging modalities help confirm the diagnosis and assess the size, location, and effect on surrounding structures.
The differential diagnosis includes other causes of proptosis such as thyroid eye disease, other orbital tumors (e.g., schwannoma, hemangiopericytoma, solitary fibrous tumor), carotid-cavernous fistula, and optic nerve tumors like meningioma or glioma.
Management depends on symptoms and the extent of compression. Many lesions are slow-growing and asymptomatic, and these can be safely observed with regular follow-up. However, surgical removal via orbitotomy is indicated when there is evidence of optic nerve compression, progressive vision loss, significant proptosis, or diagnostic uncertainty. Surgical outcomes are generally excellent, especially when the lesion is not located at the orbital apex, where access is more challenging.
Supportive care may be required if complications such as exposure keratopathy occur due to incomplete eyelid closure; this is typically managed with lubrication and close monitoring. Patients under observation should be educated to seek prompt evaluation if they notice any change in vision or symptoms.
The prognosis is very good. Most patients who are observed remain stable, and those who undergo surgery typically have excellent outcomes with minimal risk of recurrence. The primary complication, if untreated, is visual loss due to optic nerve compression, making timely recognition and appropriate management essential.
0 Comments
